235 related articles for article (PubMed ID: 3908727)
61. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
[TBL] [Abstract][Full Text] [Related]
62. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
Leveque B; Lambert-Zechovsky N; Cathlin C
Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
[No Abstract] [Full Text] [Related]
63. In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
Sato K; Okachi R; Matsukuma I; Mochida K; Hirata T
J Antibiot (Tokyo); 1989 Dec; 42(12):1844-53. PubMed ID: 2621166
[TBL] [Abstract][Full Text] [Related]
64. [Clinical study of S 6472 in urinary tract infection].
Takagi S; Arakawa S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Ishigami J; Umezu K; Yamanaka N; Sugimoto M
Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
[TBL] [Abstract][Full Text] [Related]
65. Treatment of acute bronchitis and pneumonia with cefaclor.
Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
[TBL] [Abstract][Full Text] [Related]
66. Comparison of complicated urinary tract infections in men and women.
Kawada Y
Infection; 1994; 22 Suppl 1():S55-7. PubMed ID: 8050798
[TBL] [Abstract][Full Text] [Related]
67. [Cefaclor dosage change with renal dysfunction].
Usuda Y; Sekine O
Jpn J Antibiot; 1985 Apr; 38(4):1141-6. PubMed ID: 4032725
[TBL] [Abstract][Full Text] [Related]
68. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
Parish LC; Aten EM
Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
[TBL] [Abstract][Full Text] [Related]
69. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis.
Randolph MF
Chemotherapy; 1988; 34(6):512-8. PubMed ID: 3243093
[TBL] [Abstract][Full Text] [Related]
70. Cefaclor in the treatment of uncomplicated gonococcal urethritis.
Harrison WO
Postgrad Med J; 1979; 55 Suppl 4():85-7. PubMed ID: 121455
[TBL] [Abstract][Full Text] [Related]
71. Three-day and seven-day treatment in acute otitis media: a double-blind antibiotic trial.
Jones R; Bain J
J R Coll Gen Pract; 1986 Aug; 36(289):356-8. PubMed ID: 3735223
[TBL] [Abstract][Full Text] [Related]
72. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
[TBL] [Abstract][Full Text] [Related]
73. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.
Iravani A; Richard GA
Antimicrob Agents Chemother; 1986 Jan; 29(1):107-11. PubMed ID: 3524418
[TBL] [Abstract][Full Text] [Related]
74. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
75. [Cefaclor and trimethoprim-sulfamethoxazole for recurrent otitis media].
Fliss DM; Krauss M; Gorodischer R; Bearman J; Lieberman A
Harefuah; 1989 Dec; 117(11):361-3. PubMed ID: 2695415
[TBL] [Abstract][Full Text] [Related]
76. Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria.
Hamilton-Miller JM; Iravani A; Brumfitt W; Byers KS; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S60-6; discussion S66-7. PubMed ID: 1287620
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of cefaclor.
Derry JE
Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
[TBL] [Abstract][Full Text] [Related]
78. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
Spath P
Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
[TBL] [Abstract][Full Text] [Related]
79. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
80. [Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
Jpn J Antibiot; 1989 Jul; 42(7):1629-66. PubMed ID: 2681864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]